February 27, 2020 in
STAMFORD, Conn., Feb. 27, 2020 /PRNewswire/ — According to the Centers for Disease Control and Prevention, Medicare spent $36 billion in 2017 treating people with end-stage renal disease – the final stage of chronic kidney disease. Further, the National Cancer Institute notes that the cost of kidney cancer in the United States currently exceeds $4.8 billion per year. Recognizing National Kidney Month this March, specialty lender Fifth Season Financial has developed a solution to help alleviate the financial strain associated with end-stage renal disease, kidney cancer, and other advanced-stage illnesses.
Relieve financial stress with the FLAG Program, a viatical alternative that uses your life insurance for a cash advance